<DOC>
	<DOCNO>NCT02368327</DOCNO>
	<brief_summary>This clinical study part BIOVACSAFE project fund Innovative Medicine Initiative . In study take small muscle biopsy order identify difference response around actual site injection compare response measure blood time .</brief_summary>
	<brief_title>Gene Expression Profiles Muscle After Immunisation</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . The participant able read understand Informed Consent Form ( ICF ) , understand study procedure . 2 . The participant sign ICF . 3 . Healthy male participant age 1845 year inclusive . 4 . BMI 1927 kg/m2 . 5 . Preimmunised Hepatitis B vaccine 6 . Hepatitis B sAb positive ( evidence vaccineinduced immunity ) 7 . Hepatitis B sAg cAb negative ( evidence lack prior/current HBV infection ) 8 . Hepatitis C HIV seronegative . 9 . Available followup duration study . 10 . Agree abstain donate blood study . 11 . The participant , opinion investigator , healthy basis , medical history , symptom direct medical examination vital sign . 1 . History hypersensitivity vaccine component history allergy opinion investigator would contraindicate participant participation 2 . Clinically significant psychiatric , cardiovascular , respiratory , hepatic , renal , gastrointestinal , endocrine , neurological ( particularly myasthenia gravis ) , immunological , haematological disease abnormality , determine study physician . 3 . Known immune coagulation disorder clinically significant abnormality platelet , Hb coagulation screen labs 4 . Known allergy injected local anaesthetic 5 . Unwilling undergo muscle biopsy 6 . Use steroid immunosuppressive/immunomodulating drug either orally parenterally within 3 month visit 1 . 7 . Currently participate clinical trial investigational non investigational drug device , participate another clinical trial within 3 month precede study . 8 . Any condition , investigator 's opinion , compromise participant 's ability meet protocol requirement complete study . 9 . Receipt blood product immunoglobin , within 3 month visit 1 . 10 . Unable read speak English fluency level adequate full comprehension procedure require participation consent .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>